Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 20:00
Insulet Enterprise Value : 10.69B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 10.69B |
| August 20, 2026 | 10.60B |
| August 19, 2026 | 10.92B |
| August 18, 2026 | 10.68B |
| August 17, 2026 | 10.10B |
| August 14, 2026 | 10.35B |
| August 13, 2026 | 10.57B |
| August 12, 2026 | 10.47B |
| August 11, 2026 | 10.45B |
| August 10, 2026 | 10.32B |
| August 07, 2026 | 10.20B |
| August 06, 2026 | 10.07B |
| August 05, 2026 | 9.655B |
| August 04, 2026 | 11.98B |
| August 03, 2026 | 12.18B |
| July 31, 2026 | 11.88B |
| July 30, 2026 | 11.90B |
| July 29, 2026 | 12.25B |
| July 28, 2026 | 12.03B |
| July 27, 2026 | 11.86B |
| July 24, 2026 | 11.74B |
| July 23, 2026 | 11.40B |
| July 22, 2026 | 11.44B |
| July 21, 2026 | 11.77B |
| July 20, 2026 | 12.02B |
| Date | Value |
|---|---|
| July 17, 2026 | 11.79B |
| July 16, 2026 | 11.82B |
| July 15, 2026 | 11.46B |
| July 14, 2026 | 11.45B |
| July 13, 2026 | 11.65B |
| July 10, 2026 | 11.60B |
| July 09, 2026 | 11.39B |
| July 08, 2026 | 11.33B |
| July 07, 2026 | 11.62B |
| July 06, 2026 | 11.49B |
| July 02, 2026 | 11.82B |
| July 01, 2026 | 11.50B |
| June 30, 2026 | 10.97B |
| June 29, 2026 | 11.39B |
| June 26, 2026 | 11.43B |
| June 25, 2026 | 11.12B |
| June 24, 2026 | 10.78B |
| June 23, 2026 | 10.43B |
| June 22, 2026 | 10.09B |
| June 18, 2026 | 10.56B |
| June 17, 2026 | 10.41B |
| June 16, 2026 | 10.70B |
| June 15, 2026 | 10.73B |
| June 12, 2026 | 10.84B |
| June 11, 2026 | 10.80B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 229.49B |
| DexCom, Inc. | 34.30B |
| Boston Scientific Corp. | 85.09B |
| PROCEPT BioRobotics Corp. | 1.091B |
| Globus Medical, Inc. | 11.18B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 95.00M |
| Revenue (Quarterly) | 801.70M |
| Total Expenses (Quarterly) | 706.70M |
| EPS Diluted (Quarterly) | 1.066 |
| Gross Profit Margin (Quarterly) | 72.56% |
| Profit Margin (Quarterly) | 11.85% |
| Earnings Yield | 3.46% |
| Operating Earnings Yield | 5.04% |
| Normalized Earnings Yield | 3.402 |